C4 glomerulopathy primary prevention: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) Created page with "__NOTOC__ {{C4 glomerulopathy}} {{CMG}}; {{APM}}; {{AE}} {{OO}} ==Overview== ==Primary Prevention== ==References== {{Reflist|2}} {{WH}}{{WS}}" |
Norina Usman (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Primary Prevention== | ==Primary Prevention== | ||
There are no established measures for the primary prevention of C4 glomerulopathy. | |||
==References== | ==References== | ||
Revision as of 01:05, 3 August 2020
|
C4 glomerulopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
C4 glomerulopathy primary prevention On the Web |
|
American Roentgen Ray Society Images of C4 glomerulopathy primary prevention |
|
Risk calculators and risk factors for C4 glomerulopathy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
Primary Prevention
There are no established measures for the primary prevention of C4 glomerulopathy.